Ruby Capital Investment Fund Sapphire II

Ruby Capital Investment Fund Sapphire II is an Israeli private investment fund managed by Ruby Capital, a firm specializing in real estate financing and investments. Established as a limited partnership, the fund focuses on providing equity and mezzanine financing to mid-market real estate developers in Israel for residential and mixed-use development projects. While it has attracted investment from healthcare-related entities such as Oramed Pharmaceuticals, the fund's primary operations and assets are centered in the Israeli real estate sector rather than life sciences or biotechnology. The fund aims to support developers through various stages of project lifecycles, including construction and pre-permit funding.